Japanese patent,
European classification,
Significantly positive results for Phase I trials,
Japanese Partner,
Japanese Director.
RGS is not the most exciting biotech when it comes to communication, but it's hard to deny they deliver on promises.
And all financial indicators are now very positive, creating the opportunity to finance (borrow?) their commercialisation plan in Japan and Europe: communication, marketing, sales.
Well done.
- Forums
- ASX - By Stock
- On track
Japanese patent, European classification, Significantly positive...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGS (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.532M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 914255 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 582195 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 914255 | 0.005 |
4 | 2065000 | 0.004 |
5 | 2473664 | 0.003 |
2 | 800000 | 0.002 |
5 | 4600990 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 582195 | 6 |
0.007 | 689621 | 5 |
0.008 | 249192 | 1 |
0.009 | 165746 | 1 |
0.011 | 22500 | 1 |
Last trade - 19.00pm 29/03/2024 (20 minute delay) ? |
|
|||||
Last
0.5¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.5¢ | 0.5¢ | 13888 | ||
Last updated 15.27pm 29/03/2024 ? |
Featured News
RGS (ASX) Chart |
Day chart unavailable